Humanized anti-ERBB2 antidbodies and treatment with anti-ERBB2 antibodies

Details for Australian Patent Application No. 2005242195 (hide)

Owner Genentech, Inc.

Inventors Sliwkowsky, Mark; Adams, Camellia W; Presta, Leonard G

Agent Griffith Hack

Pub. Number AU-B-2005242195

Parent 784045

Filing date 7 December 2005

Wipo publication date 12 January 2006

Acceptance publication date 11 June 2009

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Event Publications

5 January 2006 Complete Application Filed

12 January 2006 Application Open to Public Inspection

  Published as AU-B-2005242195

11 June 2009 Application Accepted

  Published as AU-B-2005242195

8 October 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005242196-Expression cassettes for meristempreferential expression in plants

2005242194-A trusted electronic messaging system